Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German gastric ulcer study

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 4, 1996, Pages 343-349

  Bayerdörffer, Ekkehard ^a   Miehlke, Stephan ^a   Lehn, Norbert ^b   Mannes, Gerd A ^c   Höchter, Wilhelm ^d   Weingart, Josef ^d   Klann, Hermann ^e   Sommer, Albrecht ^f   Heldwein, Walter ^g   Hatz, Rudolf ^h   Simon, Thomas ^d   Bolle, Karl Heinrich ⁱ   Bästlein, Elke ^f   Meining, Alexander ^a   Ruckdeschel, Gotthard ^g   Stolte, Manfred ^j  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Krankhs der Barmherzigen Bruder   (Germany)

^d Gastroenterological Practitioners   (Germany)

^e Gastroenterological Practitioner   (Germany)

^f Gastroenterological Practitioner   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ Medical Department   (Germany)

^j INSTITUTE OF PATHOLOGY   (Germany)

more..

Author keywords

Gastric ulcer; Gastric ulcer relapse; Helicobacter pylori; Omeprazole; Triple therapy

Indexed keywords

AMOXICILLIN; ANTIULCER AGENT; BISMUTH SALICYLATE; OMEPRAZOLE; TINIDAZOLE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FOLLOW UP; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SKIN ALLERGY; SLEEP DISORDER; STOMACH ULCER; STOMATITIS; TASTE DISORDER; VOMITING;

EID: 9344266330     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199604000-00011     Document Type: Article

References (32)

1. Eidt S, Stolte M: Differences between Helicobacter pylori associated gastritis in patients with duodenal ulcer, pyloric ulcer, other gastric ulcer, and gastritis without ulcer. In Helicobacter pylori, Gastritis and Peptic Ulcer. Edited by P Malfertheiner, H Ditschuneit. Springer-Verlag; 1990:228-236.
2. Maaroos H-I, Kekki M, Sipponen P, Salupere V, Villako K: Grade of Helicobacter pylori colonisation, chronic gastritis and relative risks of contracting high gastric ulcers: a seven-year follow-up. Scand J Gastroenterol 1991, 26(suppl 186):65-72.
3. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackburn SJ, et al.: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988, ii:1437-1442.
4. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ: Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study on its prevalence and the effects of antibacterial and anti-ulcer treatment. Gastroenterol 1988, 94:33-40.
5. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990, ii:1233-1235.
6. George LL, Borody TJ, Andrews P, Devine M, Moore-Jones D, Walton M et al.: Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990, 153:145-149.
7. Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hatz R et al.: High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992, 4:697-702.
8. Manner CA, Bayerdörffer E, Höchter W, Weingart J, Heldwein W, Sommer A et al.: Decreased relapse rate after antibacterial treatment of Helicobacter pylori-associated duodenal ulcers. Munich Duodenal Ulcer Trial. Eur J Gastroenterol Hepatol 1993, 5:145-153.
9. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K et al.: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New Engl J Med 1993, 328:308-312.
10. Bayerdörffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T et al.: Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992, 102:1575-1582.
11. Graham DY, Ginger M, Lew NW, Klein PD, Evans DG, Evans DJ et al.: Effect of treatment of Helicobacter pylori infection on long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992, 116:705-708.
12. Labenz J, Börsch G: Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994, 35:19-22.
13. Seppälä K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH, and the FGUSG: Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Gut 1995, 36:834-837.
14. Sung JJY, Chung S, Ling TKW, Yung MY, Leung VKS, Ng EKW, et al.: Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. New Engl J Med 1995, 332:139-142.
15. Tytgat GNJ: Colloidal bismuth subcitrate in peptic ulcer - a review. Digestion 1987, 37(suppl 2):31-41.
16. Marshall BJ, Armstrong JA, Francis GJ, Nokes NT, Wee SH: Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 1987, 17(suppl 2):16-30.
17. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M: Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988, 41:207-210.
18. Fiocca R, Villiani L, Luinetti O, Gianatti A, Boldorini R, Lazzaroni M et al.: Helicobacter pylori (HP) eradication and sequential clearance of inflammation in duodenal ulcer patients treated with omeprazole and antibiotics. Vth Workshop on gastroduodenal pathology and Helicobacter pylori. Dublin, July 5-7, 1992. Ir J Med Sci 1992, 161(suppl 10):93.
19. Weil J, Bell GD, Powell K, Morden A, Harrison G, Gant PW, Jones PH et al.: Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther 1990, 4:651-657.
20. Kasper G, Dickgießser N: Antibiotic sensitivity of 'Campylobacter pylori'. Eur J Clin Microbiol 1984, 3:444.
21. Adeyemi EO, Fadlalla H, Al-Homsi M, Nnalue NA, Goodwin S, Boehme D, et al. Clinicopathological assessment of gastric biopsy samples of patients with Helicobacter pylori infection - metronidazole resistance and compliance problems in the United Arab Emirates. Ital J Gastroenterol 1992, 24:436-439.
22. Banatvala N, Davies GR, Abdi Y, Rampton DS, Feldman R: 95% metronidazole resistance in H. pylori infection in a UK Asian community. Gastroenterology 1993, 104:A37.
23. Hirschl AM, Hentschel E, Schütze K, Nemec H, Pötzi R, Gangl A et al.: The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 1988, 23(suppl 142):76-81.
24. Glupczynski Y, Labre M, Burette A, Delmee M, Avesani V, Bruck C: Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet 1987, i:1096.
25. Unge P, Gad A, Eriksson K, Bergman B, Carling L, Ekström P et al.: Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993, 5:325-331.
26. Labenz J, Gyenes E, Ruhl G, Börsch G: Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol1993, 88:491-495.
27. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD et al.: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992, 102:493-496.
28. Cutler AF, Schubert TT: Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993, 88:505-509.
29. Labenz J, Gyenes E, Rühl C, Börsch C: Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, and controlled study. Gut 1993, 34:1167-1170.
30. Glupzynski Y, Burette A, DeKoster E, Nyst JF, Deltenre M: Metronidazole resistance in Helicobacter pylori. Lancet 1990, i:976-977.
31. Walan A, Bader J-P, Classen M, Lamers BHW, Piper DW et al.: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. New Engl J Med 1989, 320:69-75.
32. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994, 272:65-69.